missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Canine RAGE ELISA Kit
Descripción
La RAGE canina cuantifica la RAGE canina en suero, plasma y sobrenadante. El ensayo reconocerá exclusivamente la RAGE canina natural y recombinante.
The Receptor for Advanced Glycation End-products (RAGE) is a gene located on human chromosome 6p21.3, encoding a transmembrane receptor belonging to the immunoglobulin superfamily. RAGE is expressed in various tissues, with significant levels in the lungs, and plays a crucial role in cellular signaling and inflammation. As a receptor, RAGE binds multiple ligands, including advanced glycation end-products (AGEs), amyloid-beta peptide, high mobility group box 1 (HMGB1), and S100/calgranulin proteins, facilitating diverse pathological processes like inflammation, cancer progression, and neurodegeneration. The interaction between RAGE and its ligands triggers intracellular signaling pathways such as NF-kB activation, leading to inflammatory responses and oxidative stress. In the context of chronic diseases like diabetes, Alzheimer's, and cardiovascular diseases, RAGE is a critical mediator, linking metabolic disturbance to cellular dysfunction. Therapeutic targeting of RAGE signaling is under investigation, aiming to mitigate its contribution to inflammatory and degenerative diseases.
Especificaciones
Especificaciones
| Número de acceso | Receptor avanzado de producto final de glicosilación; receptor avanzado de productos finales de glicosilación; receptor avanzado específico de producto final de glicosilación; variante 2 avanzada de receptor específico de producto final de glicosilación; variante 3 avanzada de receptor específico de producto final de glicosilación; variante 4 avanzada de receptor específico de producto final de glicosilación 5; AGER; Rage; isoforma de RAGE NtRAGE-delta; isoforma de RAGE; RAGE-esRAGE; delta de isoforma; RAGE; RAGE; delta de esRAGE; GIA; Rage/AGER; RAGE-4 ORF3; receptor para la variante 20 de productos finales de glicosilación avanzada; receptor para productos finales de glicosilación avanzada; SCARJ1; sRAGE |
| Intervalo del ensayo | De 16 a 4000 pg/ml |
| Sensibilidad del ensayo | 16 pg/mL |
| Conjugado | Biotina |
| Formato del kit de inmunoensayo | Sandwich ELISA Kit |
| Tipo de producto | ELISA |
| Tipo de muestra | Plasma, Sobrenadante, Suero |
| Especies diana | Canine |
| Para utilizar con (equipo) | Lector de microplacas colorimétrico |
| Alias de gen | advanced glycation end product receptor; advanced glycation end-product receptor; advanced glycation end-products receptor; advanced glycosylation end product-specific receptor; advanced glycosylation end product-specific receptor variant 2; advanced glycosylation end product-specific receptor variant 3; advanced glycosylation end product-specific receptor variant 4; advanced glycosylation end product-specific receptor variant 5; advanced glycosylation end-product specific receptor; Ager; MAPK/MAK/MRK overlapping kinase; MOK; MOK protein kinase; RAGE; RAGE isoform NtRAGE-delta; RAGE isoform sRAGE-delta; RAGE/AGER; RAGE1; RAGE-1; RAGE-4 ORF3; receptor for advanced glycation endproducts; receptor for advanced glycation end-products variant 20; receptor for advanced glycosylation end products; receptor of advanced glycosylation end products of proteins; immunoglobulin superfamily; MHC class II; MHC class III; renal cell carcinoma antigen; renal tumor antigen 1; SCARJ1; sRAGE; STK30advanced glycation end product receptor; advanced glycation end-product receptor; advanced glycation end-products receptor; advanced glycosylation end product-specific receptor; advanced glycosylation end product-specific receptor variant 2; advanced glycosylation end product-specific receptor variant 3; advanced glycosylation end product-specific receptor variant 4; advanced glycosylation end product-specific receptor variant 5; advanced glycosylation end-product specific receptor; Ager; MAPK/MAK/MRK overlapping kinase; MOK; MOK protein kinase; RAGE; RAGE isoform NtRAGE-delta; RAGE isoform sRAGE-delta; RAGE/AGER; RAGE1; RAGE-1; RAGE-4 ORF3; receptor for advanced glycation endproducts; receptor for advanced glycation end-products variant 20; receptor for advanced glycosylation end products; receptor of advanced glycosylation end products of proteins; immunoglobulin superfamily; MHC class II; MHC class III; renal cell carcinoma antigen; renal tumor antigen 1; SCARJ1; sRAGE; STK30; |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?